News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
553,568 Results
Type
Article (14558)
Company Profile (148)
Press Release (538862)
Multimedia
Podcasts (6)
Webinars (9)
Section
Business (184416)
Career Advice (879)
Deals (28739)
Drug Delivery (31)
Drug Development (61634)
Employer Resources (48)
FDA (11796)
Job Trends (9969)
News (267830)
Policy (21244)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1005)
Accelerated approval (34)
ADA (23)
Adcomms (8)
Allergies (131)
Alliances (37768)
ALS (157)
Alzheimer's disease (1254)
Antibody-drug conjugate (ADC) (369)
Approvals (12479)
Artificial intelligence (474)
ASCO (195)
Autoimmune disease (253)
Automation (44)
Bankruptcy (287)
Best Places to Work (8165)
BIO (40)
BIOSECURE Act (5)
Biosimilars (141)
BioSpace Insights (41)
Biotechnology (100)
Bladder cancer (176)
Brain cancer (45)
Breast cancer (613)
Cancer (4599)
Cardiovascular disease (304)
Career advice (728)
Career pathing (13)
CAR-T (212)
CDC (6)
Celiac Disease (1)
Cell therapy (620)
Cervical cancer (38)
Clinical research (55379)
Collaboration (1578)
Commercialization (2)
Compensation (1457)
Complete response letters (40)
COVID-19 (1230)
CRISPR (73)
C-suite (944)
Cystic fibrosis (106)
Data (6927)
Denatured (5)
Depression (123)
Dermatology (71)
Diabetes (417)
Diagnostics (5193)
Digital health (49)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (218)
Drug pricing (34)
Drug shortages (11)
Duchenne muscular dystrophy (197)
Earnings (80076)
Editorial (14)
Employer branding (7)
Employer resources (46)
Events (95423)
Executive appointments (864)
FDA (15030)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (26)
Funding (1171)
Gene editing (154)
Generative AI (22)
Gene therapy (436)
GLP-1 (413)
Government (1613)
Grass and pollen (2)
Guidances (365)
Healthcare (11942)
Hematology (121)
HIV (61)
Huntington's disease (35)
IgA nephropathy (84)
Immunology and inflammation (129)
Immuno-oncology (74)
Indications (184)
Infectious disease (1449)
Inflammatory bowel disease (158)
Inflation Reduction Act (4)
Influenza (92)
Intellectual property (282)
Interviews (180)
IPO (13813)
IRA (5)
Job creations (2207)
Job search strategy (610)
JPM (12)
Kidney cancer (22)
Labor market (6)
Layoffs (113)
Leadership (16)
Legal (5661)
Licensing (5)
Liver cancer (64)
Longevity (20)
Lung cancer (609)
Lymphoma (309)
Machine learning (42)
Management (20)
Manufacturing (737)
Marketing (10)
MASH (163)
Medical device (10164)
Medtech (10325)
Mergers & acquisitions (16125)
Metabolic disorders (902)
mRNA (96)
Multiple sclerosis (141)
NASH (9)
Neurodegenerative disease (299)
Neuropsychiatric disorders (49)
Neuroscience (2371)
NextGen: Class of 2026 (3855)
Non-profit (1430)
Obesity (300)
Opinion (79)
Ovarian cancer (189)
Pain (194)
Pancreatic cancer (277)
Parkinson's disease (263)
Partnered (17)
Patents (536)
Patient recruitment (625)
Peanut (51)
People (45353)
Pharmaceutical (31)
Pharmacy benefit managers (14)
Phase 1 (17666)
Phase 2 (24593)
Phase 3 (17194)
Pipeline (8524)
Policy (64)
Postmarket research (1815)
Preclinical (7667)
Press Release (39)
Prostate cancer (252)
Psychedelics (15)
Radiopharmaceuticals (259)
Rare diseases (746)
Real estate (3571)
Recruiting (16)
Regulatory (17891)
Reports (22)
Research institute (1172)
Resumes & cover letters (132)
Rett syndrome (47)
RNA editing (11)
RSV (54)
Schizophrenia (127)
Series A (192)
Series B (152)
Service/supplier (5)
Sickle cell disease (80)
Special edition (1)
Spinal muscular atrophy (140)
Sponsored (21)
Startups (2325)
State (1)
Stomach cancer (6)
Supply chain (71)
Tariffs (14)
The Weekly (1)
Vaccines (485)
Venture capital (31)
Weight loss (113)
Women's health (90)
Worklife (5)
Date
Today (38)
Last 7 days (605)
Last 30 days (1710)
Last 365 days (22892)
2026 (14095)
2025 (22934)
2024 (27018)
2023 (31095)
2022 (40510)
2021 (43534)
2020 (39828)
2019 (28637)
2018 (21478)
2017 (22298)
2016 (21108)
2015 (27745)
2014 (24019)
2013 (20008)
2012 (22175)
2011 (22417)
2010 (21917)
Location
Africa (372)
Alabama (81)
Alaska (3)
Arizona (318)
Arkansas (11)
Asia (24378)
Australia (3543)
California (12721)
Canada (3475)
China (779)
Colorado (530)
Connecticut (504)
Delaware (287)
Europe (40941)
Florida (1951)
Georgia (391)
Hawaii (3)
Idaho (51)
Illinois (825)
India (66)
Indiana (441)
Iowa (18)
Japan (458)
Kansas (113)
Kentucky (36)
Louisiana (32)
Maine (54)
Maryland (1369)
Massachusetts (8761)
Michigan (324)
Minnesota (635)
Mississippi (4)
Missouri (121)
Montana (27)
Nebraska (16)
Nevada (131)
New Hampshire (66)
New Jersey (3118)
New Mexico (19)
New York (3214)
North Carolina (1449)
North Dakota (7)
Northern California (6439)
Ohio (323)
Oklahoma (18)
Oregon (23)
Pennsylvania (2420)
Puerto Rico (22)
Rhode Island (34)
South America (587)
South Carolina (80)
South Dakota (1)
Southern California (5184)
Tennessee (191)
Texas (2069)
United States (43110)
Utah (381)
Vermont (1)
Virginia (233)
Washington D.C. (45)
Washington State (998)
West Virginia (2)
Wisconsin (103)
Wyoming (2)
553,568 Results for "trace ability inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology
July 29, 2026
·
4 min read
NextGen
Trace Unites ALS Teams Behind a Target That Could Broaden Treatment Access
Trace Neuroscience, a member of
BioSpace
’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims to bring more treatment options to the ALS community.
March 25, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Agilent Launches 1290 Infinity III Fluorescence Detector for Confident Trace Analysis at UHPLC Speed
May 21, 2026
·
2 min read
Press Releases
Trace Neuroscience Initiates Global Clinical Development Program for TRCN-1023, an Antisense Oligonucleotide Designed to Restore UNC13A Function for the Treatment of ALS
June 23, 2026
·
5 min read
Press Releases
Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agent
February 2, 2026
·
3 min read
Press Releases
Ability Biotherapeutics Appoints Angèle Maki, PhD, as Chief Business Officer
December 10, 2025
·
3 min read
Press Releases
Progentec Diagnostics Advances Ability to Determine Lupus Risk with New Research and OCAST Grant
April 10, 2026
·
2 min read
Press Releases
Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC
June 1, 2026
·
3 min read
Press Releases
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
April 1, 2025
·
3 min read
Press Releases
Tubulis Unveils Alco5 Conjugation Platform’s Ability to Expand ADC Payload Scope in Nature Communications
January 21, 2026
·
3 min read
1 of 55,357
Next
